VANGUARD DIAGNOSTICS PRIVATE LIMITED

New Delhi-based Vanguard Diagnostics generated a revenue of Rs 23 crore during the FY 20-21, doubling its business in comparison to the revenue generation of Rs 10 crore during the FY 19-20. During the pandemic, Vanguard collaborated with IIT Delhi for the development of an aptamer based novel test for the detection of COVID-19 antigen. Vanguard Diagnostics was amongst the first few companies in India to obtain the NIV ICMR validation approval for its rapid card test for the detection of IgM and IgG antibodies against the coronavirus. The company ramped up its manufacturing capacity by four times to meet the market demand for viral transport media.